Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H McCabe

Showing results (191-200 of 259) with videos related to

Pageof 26
Sort By:
American Heart Journal|September 26, 2006
Early initiation of eptifibatide in the emergency department before primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: results of the Time to Integrilin Therapy in Acute Myocardial Infarction (TITAN)-TIMI 34 trialC Michael Gibson, Ajay J Kirtane, Sabina A Murphy, et al.
Circulation|October 12, 1999
Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) 11B trialE M Antman, C H McCabe, E P Gurfinkel, et al.
European Heart Journal|June 30, 2007
Efficacy and safety of the low-molecular weight heparin enoxaparin compared with unfractionated heparin across the acute coronary syndrome spectrum: a meta-analysisSabina A Murphy, Charles Michael Gibson, David A Morrow, et al.
The American Journal of Cardiology|October 7, 1997
Prospective validation of a composite end point in thrombolytic trials of acute myocardial infarction (TIMI 4 and 5). Thrombosis In Myocardial InfarctionC P Cannon, P J Sharis, M J Schweiger, et al.
European Heart Journal|November 1, 2001
Availability of on-site catheterization and clinical outcomes in patients receiving fibrinolysis for ST-elevation myocardial infarctionJ Llevadot, R P Giugliano, E M Antman, et al.
Circulation|July 13, 2000
Oral glycoprotein IIb/IIIa inhibition with orbofiban in patients with unstable coronary syndromes (OPUS-TIMI 16) trialC P Cannon, C H McCabe, R G Wilcox, et al.
European Heart Journal|July 22, 1999
Factors associated with failure of medical therapy in patients with unstable angina and non-Q wave myocardial infarction. A TIMI-IIIB database studyP H Stone, B Thompson, B L Zaret, et al.
Journal of the Neurological Sciences|June 24, 2025
Pilot study of on-treatment platelet reactivity at low shear stress and platelet activation status on aspirin or clopidogrel monotherapy in patients with TIA or ischaemic strokeS T Lim, S J X Murphy, D R Smith, et al.
European Heart Journal|June 19, 2002
Determinants of improvement in epicardial flow and myocardial perfusion for ST elevation myocardial infarction; insights from TIMI 14 and InTIME-IIE M Antman, H A Cooper, C M Gibson, et al.
European Heart Journal|July 3, 2004
The Risk Score Profile: a novel approach to characterising the risk of populations enrolled in clinical studiesDavid A Morrow, Elliott M Antman, Sabina A Murphy, et al.
Pageof 26

Showing results (191-200 of 259) with videos related to

Sort By:
Pageof 26
American Heart Journal|September 26, 2006
Early initiation of eptifibatide in the emergency department before primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: results of the Time to Integrilin Therapy in Acute Myocardial Infarction (TITAN)-TIMI 34 trialC Michael Gibson, Ajay J Kirtane, Sabina A Murphy, et al.
Circulation|October 12, 1999
Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) 11B trialE M Antman, C H McCabe, E P Gurfinkel, et al.
European Heart Journal|June 30, 2007
Efficacy and safety of the low-molecular weight heparin enoxaparin compared with unfractionated heparin across the acute coronary syndrome spectrum: a meta-analysisSabina A Murphy, Charles Michael Gibson, David A Morrow, et al.
The American Journal of Cardiology|October 7, 1997
Prospective validation of a composite end point in thrombolytic trials of acute myocardial infarction (TIMI 4 and 5). Thrombosis In Myocardial InfarctionC P Cannon, P J Sharis, M J Schweiger, et al.
European Heart Journal|November 1, 2001
Availability of on-site catheterization and clinical outcomes in patients receiving fibrinolysis for ST-elevation myocardial infarctionJ Llevadot, R P Giugliano, E M Antman, et al.
Circulation|July 13, 2000
Oral glycoprotein IIb/IIIa inhibition with orbofiban in patients with unstable coronary syndromes (OPUS-TIMI 16) trialC P Cannon, C H McCabe, R G Wilcox, et al.
European Heart Journal|July 22, 1999
Factors associated with failure of medical therapy in patients with unstable angina and non-Q wave myocardial infarction. A TIMI-IIIB database studyP H Stone, B Thompson, B L Zaret, et al.
Journal of the Neurological Sciences|June 24, 2025
Pilot study of on-treatment platelet reactivity at low shear stress and platelet activation status on aspirin or clopidogrel monotherapy in patients with TIA or ischaemic strokeS T Lim, S J X Murphy, D R Smith, et al.
European Heart Journal|June 19, 2002
Determinants of improvement in epicardial flow and myocardial perfusion for ST elevation myocardial infarction; insights from TIMI 14 and InTIME-IIE M Antman, H A Cooper, C M Gibson, et al.
European Heart Journal|July 3, 2004
The Risk Score Profile: a novel approach to characterising the risk of populations enrolled in clinical studiesDavid A Morrow, Elliott M Antman, Sabina A Murphy, et al.
Pageof 26